Skip to content

Application and Effect Evaluation Study of Three-Dimensional Visualization Technology in Anatomical Liver Resection

Application and Effect Evaluation Study of Three-Dimensional Visualization Technology in Anatomical Liver Resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105319
Enrollment
Unknown
Registered
2025-07-02
Start date
2024-08-06
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumors (such as hepatocellular carcinoma), intrahepatic bile duct stones, benign focal liver lesions

Interventions

Experimental group:Prior to surgery, utilize three-dimensional visualization technology to create a detailed reconstruction of the patients liver anatomy, including precise representations of intrahep
Control group:Using traditional methods, surgeons plan and perform surgeries based on their experience and interpretation of two-dimensional images (such as CT scans, MRI scans, etc.).

Sponsors

The Fifth Medical Center of the Chinese People's Liberation Army General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 65 years. 2.Patients requiring anatomical liver resection surgery. 3.Liver function results suitable for surgical resection. 4.Obtain valid imaging examination results. 5.Generally in good health condition, able to tolerate the surgical and anesthesia procedures.

Exclusion criteria

Exclusion criteria: 1.Patients with severe heart disease, lung disease, or other systemic illnesses that make them unsuitable for surgical intervention. 2.Patients with severe liver dysfunction. 3.Patients who have undergone other therapeutic interventions that may affect the extent of surgical resection. 4.Poor quality of imaging examinations, making accurate application of three-dimensional visualization technology not feasible. 5.Patients with active infections or severe immunodeficiency. 6.Patients with mental illness or cognitive impairments who cannot understand and comply with the study requirements.

Design outcomes

Primary

MeasureTime frame
Surgical time;Blood loss;Postoperative complications;Surgical incision length;Postoperative recovery time;

Secondary

MeasureTime frame
Postoperative pain scores;Length of hospital stay;Postoperative liver function recovery;

Countries

China

Contacts

Public ContactZhijie Li

The Fifth Medical Center of the Chinese People's Liberation Army General Hospital

jjtony10@163.com+86 10 6693 3487

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026